Crafting and delivering a compelling pitch to investors is essential for both first-time founders and seasoned professionals in the cell and gene therapy field. In this webinar, we’ll break down the anatomy of a successful pitch and dive into key strategies for tailoring your message to different investor types. We’ll also cover the crucial “dos and don’ts” that can make or break your presentation. Learn how to handle the next steps after a pitch, whether it’s a success or a setback. Additionally, we’ll explore the distinct approaches when you are seeking seed/early-stage versus later-stage financing, helping you navigate each with confidence. While touching on some basics, our focus will be on delivering practical, real-world advice and actionable examples from successful pitches. Don’t miss this opportunity to enhance your pitching skills and increase your chances of securing funding.

Join us for an engaging webinar where we explore the art of crafting and delivering impactful elevator pitch presentations. Discover proven strategies and techniques to captivate your audience and leave a lasting impression when showcasing your innovative research. Our speakers, including previous elevator pitch judges and winners, will share invaluable insights on composing your pitch, refining your message, and mastering delivery techniques to confidently showcase your ideas. Plus, you'll have dedicated exercise time to practice and receive feedback on your pitch. Whether you're a seasoned professional or just starting out, this webinar will equip you with the skills and confidence to make every elevator pitch count. Don't miss out – register now and elevate your presentation game!

Non-regulated and unproven stem cell therapies continue to pose risks to patients, and aggressive and deceptive marketing tactics often blur the line between hope and fraud. In this webinar, you will gain insights from a landmark class action lawsuit against a clinic that falsely claimed to regenerate lung tissue. Despite lacking scientific evidence, the clinic used deceptive marketing to mislead patients—until legal action shut it down and secured a multi-million-dollar verdict for those affected. This session will also explore the vital role of scientific and medical experts in litigation. Learn how researchers and clinicians can contribute to legal proceedings, provide expert opinions, and uphold ethical standards in the rapidly evolving field of cell and gene therapy. We will discuss the litigation process, protections for expert witnesses, and how expert testimony can safeguard patient trusts and drive regulatory improvements.

One of the biggest headlines for our field was the recent approval of Ryoncil - we're delighted to have Silviu Itescu, MBBA, FRACP, CEO of Mesoblast, as the featured presenter for this town hall meeting. This is your chance to not only get the inside details from the Mesoblast breakthrough, but to also connect with the ISCT Community and meet our North America leadership team in this virtual forum - if you're a cell and gene therapy therapy professional, there's a lot of value for you! Among key updates for the region, you'll hear of some exciting highlights from our team - selected sessions and programs that they (and you!) don’t want to miss at the ISCT 2025 Annual Meeting in New Orleans.

Organized by the ISCT ESP Committee: Mentoring & Career Development Working Group. Are you seeking to unlock funding opportunities for your projects but unsure of where to start? Register for the ISCT Early-Stage Professionals’ informative webinar designed to equip you with essential skills in grant writing. Whether you’re new to grant writing or looking to refine your skills, in this interactive session, we will cover the essentials of navigating the world of grants and funding opportunities from USA and EU perspectives. You will learn the ins and outs of the grant application process, from understanding different funding sources to crafting compelling proposals that resonate with funders. In addition, you will receive guidance on developing a funding plan, along with career strategies that can significantly improve your chances of securing competitive research funding. Our expert speakers will share their knowledge and experiences, helping you navigate common challenges and pitfalls in grant writing. Take charge of your career development and don't miss an opportunity to gain valuable insights and practical tips that can help you navigate the grant writing process with confidence.

WEBINAR DESCRIPTION: Join the International Society for Cell & Gene Therapy (ISCT) for an in-depth webinar on the evolving reimbursement landscape for CAR-T therapy. This session is essential for professionals navigating the complexities of cost, coverage, and regulatory considerations associated with CAR-T treatments. The webinar will be led by industry experts discussing recent developments in CAR-T reimbursement. Participants will explore case studies showing how policies impact patient access to CAR-T therapy, highlighting challenges and opportunities. Additionally, participants will gain knowledge and evidence to engage with policymakers and stakeholders for equitable reimbursement policies, ensuring timely and affordable access for patients.

Hosted by the ISCT Asia Regional Leadership, this Town Hall offers the opportunity to learn about key priorities in the region, how to get the most out of your membership with ISCT, and ways you can actively participate and contribute. Gain insights directly from our current leaders into resources and initiatives aimed at supporting our members in the region. This recording also features presentations from our guest speakers: Shin Kawamata, MD, PhD, CEO of Cyto-Facto Inc. and Huji Xu, PhD, Professor of Medicine at Tsinghua University.

WEBINAR DESCRIPTION: In October 2023, the FDA issued a guidance document on Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies. This guidance describes a standards recognition program for regenerative medicine therapies (SRP-RMT) at FDA’s Center for Biologics Evaluation and Research (CBER) designed to identify and recognize Voluntary Consensus Standards (VCS) to facilitate the development and assessment of regenerative medicine therapy (RMT) products regulated by CBER when such standards are appropriate. Standardization bodies such as Standards Coordinating Body (SCB) and the American National Standards Institute (ANSI) have helped to introduce and facilitate the VCS process, however, many stakeholders are unclear about the process. This webinar will discuss the VCS process, what the stakeholders need to know, and how to develop one. A case study of an actual international consensus standard development of tissue-specific MSC biobanking, characterization, terminology with extensive and iterative input from ISCT will also be presented.

WEBINAR DESCRIPTION: In October 2023, the FDA issued a guidance document on Voluntary Consensus Standards Recognition Program for Regenerative Medicine Therapies. This guidance describes a standards recognition program for regenerative medicine therapies (SRP-RMT) at FDA’s Center for Biologics Evaluation and Research (CBER) designed to identify and recognize Voluntary Consensus Standards (VCS) to facilitate the development and assessment of regenerative medicine therapy (RMT) products regulated by CBER when such standards are appropriate. Standardization bodies such as Standards Coordinating Body (SCB) and the American National Standards Institute (ANSI) have helped to introduce and facilitate the VCS process, however, many stakeholders are unclear about the process. This webinar will discuss the VCS process, what the stakeholders need to know, and how to develop one. A case study of an actual international consensus standard development of tissue-specific MSC biobanking, characterization, terminology with extensive and iterative input from ISCT will also be presented.

WEBINAR DESCRIPTION: Join us for a deep dive into the world of CAR-T cell therapy development with our webinar titled "Navigating CAR-T Cell Therapy Development: Insights from Leading SCA Academic Centers." Organized by the ISCT South & Central America (SCA) Regional Executive Committee and the South and Central America (SCA) Regional ESP Subcommittee. The event will be co-chaired by Samuel Couto and Lilia León Moreno. The webinar will open with Virginia Picanço-Castro sharing her experience from one of Brazil's leading institutes on the complete developmental journey of a CAR-T cell product, from bench to bedside. She will provide a detailed overview of the unique manufacturing challenges faced and the innovative strategies implemented to bring CAR-T cell therapies to clinical practice in Brazil. Andres Gomez will offer valuable insights from Mexico, discussing the development and implementation of CAR-T cell therapies within the local academic and clinical landscape. He will highlight the regulatory environment and the steps required to advance this novel treatment in Mexico. Chase Mccann will conclude the session by discussing the role of clinical trials in the development of CAR-T cell therapies, drawing from his experience at Children's National Hospital. He will focus on the latest advancements in pediatric applications and share real-world insights from ongoing clinical trials. This exclusive event offers members of the International Society for Cell & Gene Therapy (ISCT) an opportunity to explore the diverse paths of CAR-T therapy development across the South & Central America region. Engage with leading experts and discover the future of CAR-T therapy, from clinical trials to regulatory challenges and beyond.